Episode 36: Using Data to Grow Your Business

Published in Data and Lead Generation on July 31, 2019

Host Brian Thompson talks to Director of VGM Market Data, Ryan Ball, about the opportunities for DMEPOS providers to utilize exclusive claims data to grow their business.

VGM Market Data is an industry leader in providing referral source targeting solutions to orthotists, prosthetists, home medical equipment providers, physical and occupational therapists and infusion drug providers in the United States. Our program provides VGM members exclusive access to the largest and most comprehensive HME, O&P, PT and Infusion claims database in the country, including more than 8 million health care practitioners and 1.2 billion claims from all major payer sources annually.

Our claims data program provides volumized targeting solutions for physicians treating relevant patients, performing surgeries or procedures, diagnosing patients with targeted disease states and those that can be connected to a claim for DMEPOS. Digging deeper, Market Data also provides competitive market share information, detailing which local provider receives business from key physicians and also ranks provider locations by volume against all other similar provider types billing for that product or service.

​VGM Market Data assists our clients with identifying, targeting, engaging and converting key physicians prescribing the products, services and therapies provided across all post-acute market segments. Contact us to learn more about how our program will allow a laser-like focus on key referral sources and growth opportunities in your market.

The VGM Market Data program provides VGM members exclusive access to the largest and most comprehensive DME, O&P, PT and Infusion claims database in the country. Contact us to learn more about this super product that will allow a laser-like focus on key referral sources and opportunities in your market.

Listen below or click here


comments powered by Disqus

From Our Experts

Operations Leadership During a Pandemic, a Chat with HOMELINK Vice Presidents of Operations thumbnail Operations Leadership During a Pandemic, a Chat with HOMELINK Vice Presidents of Operations Shannon Eckhardt, Ryan Longhorn, and Monica Rogan are all VPs of Operations at HOMELINK, a subsidiary of VGM Group. In this episode, they join us for a conversation about operations the size of HOMELINK and how this group has adapted this year during the COVID-19 pandemic. Featured Service: The van Halem Group thumbnail Featured Service: The van Halem Group There's been a lot of questions and confusion surrounding telehealth services and how they relate to DMEPOS claims. This article by Wayne van Halem, originally featured in “VGM Playbook: Technology and the Patient Care Continuum Guide to Remote Work,” addresses whether or not telehealth services can be used to qualify a patient for an item of DMEPOS during the PHE. Return of the Audits thumbnail Return of the Audits HME Business recently wrote about the news that CMS planned to resume audits by Aug. 3 and that it took many by surprise. Then CMS said it would resume audits in a phased approach. What are the details and what can providers expect? CMS Audits Resume August 3, 2020 thumbnail CMS Audits Resume August 3, 2020 In this episode, we chat with Wayne van Halem and Kelly Grahovac of The van Halem Group about the CMS audits returning today, August 3, and what DMEPOS providers need to know. Member Q&A From The van Halem Group: New Order Requirement and Member Q&A From The van Halem Group: New Order Requirement and "Master List" I'm curious about this new order requirement. I see that Medicare updated the notice on 2/12/20, and I'm curious about the “Master List” of items that still needs a WOPD. I'm wondering if PAP equipment and supplies fall under the SWO or the WOPD. Can you help me understand? The Cost of Compliance – An Impassioned Plea to be Proactive thumbnail The Cost of Compliance – An Impassioned Plea to be Proactive Last year, The van Halem Group was engaged by several DME providers that were subject to a 6-year OIG lookback audit. Sadly, for companies that did not have a process in place for proactive chart audits, the 6-year look back resulted in a very expensive lesson. Lookback audits are here to stay, and it's never been more important for providers to have a comprehensive proactive compliance program, and this is one way that The van Halem Group can assist members. OIG to Review PMD Repairs and PAP Supplies thumbnail OIG to Review PMD Repairs and PAP Supplies The Office of Inspector General (OIG) has updated its work plan to include new reviews for PAP replacement supplies and power mobility device repairs. In a recent article from HME News, Medicare paid approximately $945.8 million for replacement supplies in 2017 and 2018, but OIG has previously found that most claims did not comply with Medicare requirements and that DME suppliers often did not have the documentation required to support the need for replacement supplies. Are Inhalation Drugs the Next OIG Six Year Lookback Audit? thumbnail Are Inhalation Drugs the Next OIG Six Year Lookback Audit? Since 2010, the CMS's Comprehensive Error Rate Testing (CERT) program has identified nebulizers and related drugs (i.e., inhalation drugs) among the top 20 supplies with the highest improper Medicare payments. Based on prior reviews, the Office of Inspector General (OIG) conducted a nationwide review to determine if the suppliers included in the review complied with Medicare requirements when billing for inhalation drugs.